Combination of MIG (CXCL9) chemokine gene therapy with low-dose cisplatin improves therapeutic efficacy against murine carcinoma.
about
Chemokines and angiogenesis in rheumatoid arthritis.Angiogenesis in rheumatoid arthritis.Angiogenesis and its targeting in rheumatoid arthritisTargeting Angiogenesis in Rheumatoid ArthritisThe emerging role of CXC chemokines and their receptors in cancer.The p53 upregulated modulator of apoptosis (PUMA) chemosensitizes intrinsically resistant ovarian cancer cells to cisplatin by lowering the threshold set by Bcl-x(L) and Mcl-1CXCL9: evidence and contradictions for its role in tumor progression.Identification of actively translated mRNA transcripts in a rat model of early-stage colon carcinogenesis.The role of chemokines in intestinal inflammation and cancer.Adenovirus-mediated LIGHT gene modification in murine B-cell lymphoma elicits a potent antitumor effectChemokine-based immunotherapy: delivery systems and combination therapies.Comprehensive site-specific whole genome profiling of stromal and epithelial colonic gene signatures in human sigmoid colon and rectal tissue.The chemokine CXCL9 exacerbates chemotherapy-induced acute intestinal damage through inhibition of mucosal restitution.CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation - A target for novel cancer therapy.The Inflammatory CXC Chemokines, GROαhigh, IP-10low, and MIGlow, in Tumor Microenvironment Can Be Used as New Indicators for Non-small Cell Lung Cancer Progression.
P2860
Q33909030-089F1756-BE13-4F8F-A22F-ACE50A77BAEEQ34051829-4E66B606-465C-4F84-971D-8DA9E754FD92Q34051950-F5161FEA-F6A0-4A7C-B4E7-C08506ABFB5CQ34058895-AA12986A-4794-4D22-A7C7-F59E6831F97AQ34263645-DABA22C5-611E-4B63-B34A-3959D483CE22Q35876786-AC46FEE3-70B7-4C85-9EBE-25DC69EF147FQ37429985-1399AD3E-CA8D-4BF3-9D59-8768EE4E5C7AQ37440882-035EE6CF-B6BD-4C38-BEC0-783D777716BAQ37455621-786F60F2-D63E-4A59-A642-39FA4D7F5EBCQ37729679-A22468E3-A1CF-4D6F-8611-35B85B477F31Q38040509-ABADA318-91C3-40A6-9A68-CBDDF0C65AF7Q38843102-CFD1BAA6-7905-4DB8-9BD0-73C67A35E7CBQ38940305-4115BA46-A637-47A5-8229-4442A1323E18Q45931583-4034F2AC-FAC6-4A30-990C-34F03DBB276CQ51072169-B3947CA3-E90A-4E80-83A2-A04B9412942E
P2860
Combination of MIG (CXCL9) chemokine gene therapy with low-dose cisplatin improves therapeutic efficacy against murine carcinoma.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Combination of MIG (CXCL9) che ...... cacy against murine carcinoma.
@en
Combination of MIG
@nl
type
label
Combination of MIG (CXCL9) che ...... cacy against murine carcinoma.
@en
Combination of MIG
@nl
prefLabel
Combination of MIG (CXCL9) che ...... cacy against murine carcinoma.
@en
Combination of MIG
@nl
P2093
P2860
P356
P1433
P1476
Combination of MIG (CXCL9) che ...... cacy against murine carcinoma.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.GT.3302756
P577
2006-05-04T00:00:00Z
P5875
P6179
1017810235